Sheridan Snyder
Encyclopedia
Dr. Sheridan Gray "Sherry" Snyder OBE, LLB (born October 20, 1936), often referred to as Sherry Snyder, is an entrepreneurial figure in the biotechnology
industry and a philanthropist, who has also made significant contributions to the development of the game of tennis
.
in 2002.
and served as Chairman/President/CEO. Genzyme’s business focused on enzyme deficiency diseases. It first produced diagnostic enzymes for victims of Gaucher's disease, a rare chronic disorder causing enormous enlargement of the spleen, a change in skin pigmentation and bone lesions. It afflicts 10,000 young Hasidic Jews each year. It currently employs 10,000 people worldwide, with approximately $3.6 billion in revenues, with a market valuation of $20 billion. Genzyme (NASDAQ:GENZ) is the largest private employer in Boston, Massachusetts. In 1986, Mr. Snyder initiated the first sale of Genzyme stock shares (Initial Public Offering).
Biocatalyst International to date incorporates three dynamic companies interfacing with diverse markets of the biotechnology world. These three corporations were founded by Mr. Snyder, as he takes the biotechnology industry into the future. Biocatalyst International, Molecular MD and Xcovery are leading forces catapulting profitable biotech start-up ventures and expanding the boundaries of science today.
Mr. Snyder co-founded Xcovery with Dr. Chris Liang, Director of Medicinal Chemistry, Scripps
Research Florida, and co-developer of Sutent, Pfizer
’s first small molecule oncology drug. Xcovery has 5 lead compounds focused on cancer.
Molecular MD was co-founded with Dr. Brian Druker
, inventor of Gleevec, Director of the Cancer Center at the Oregon Health Sciences University in Portland. Oregon. Gleevec is a revolutionary small molecule drug that prevents and stops the growth of cancer cells in chronic myeloid leukemia (CML). MMD is a molecular diagnostic company in the world of personalized medicine utilizing highly sensitive detection systems.
In 2003, he was appointed to Scotland’s International Advisory Board and serves as an advisor to the Scottish government on the development of its biotech sector. In this capacity, Snyder played a major role with the development of an 800000 square feet (74,322.4 m²) bioscience translational center outside of Edinburgh.
Mr. Snyder was honored OBE (Officer of the Order of the British Empire)in 2005 by HM Queen Elizabeth II of the United Kingdom
on the advice of the British government.
In 2008 Mr. Snyder was awarded the Intercollegiate Tennis Association
Achievement Award for achievements outside the game of tennis.
He is a member of the Ivy Charitable Foundation.
and Charles Pasarell. Snyder supported the NJTL for 15 years. This organization now operates, through the USTA, in 110 cities and reaches 250,000 inner-city youths.
In 1988, Snyder was the Founder, Chairman & CEO of Compuflo Inc., which developed a specialty high-end computer program used to analyze airflow to aid the design of aircraft and autos, a company donated to the University of Virginia to support its laboratories. Snyder also funded University Technology Corporation, where companies were formed with University of Virginia technology and the proceeds generated by these business ventures were donated back to the University.
In 1995 Snyder contributed to the construction of a new tennis center at the University of Virginia which was named the Sheridan Snyder Tennis Center
.
Snyder's sale of Upstate from in 2004 resulted in a gift of US45 million to the University of Virginia Health Center which has used this gift to construct a new Children's Hospital, the Emily Couric Cancer Center and the Sheridan G. Snyder Translational Research Center.
Biotechnology
Biotechnology is a field of applied biology that involves the use of living organisms and bioprocesses in engineering, technology, medicine and other fields requiring bioproducts. Biotechnology also utilizes these products for manufacturing purpose...
industry and a philanthropist, who has also made significant contributions to the development of the game of tennis
Tennis
Tennis is a sport usually played between two players or between two teams of two players each . Each player uses a racket that is strung to strike a hollow rubber ball covered with felt over a net into the opponent's court. Tennis is an Olympic sport and is played at all levels of society at all...
.
Education
Mr. Snyder graduated from The Lawrenceville School in New Jersey and is a 1958 graduate of The University of Virginia with a Bachelor of Arts in French & Romance Languages. At UVa, Snyder was a member of the SPE social fraternity. Snyder received an Honorary Doctorate of Law degree from the University of DundeeUniversity of Dundee
The University of Dundee is a university based in the city and Royal burgh of Dundee on eastern coast of the central Lowlands of Scotland and with a small number of institutions elsewhere....
in 2002.
Early Business Career
Upon graduation from UVA, Snyder began his career as a Credit Analyst for New York Trust Corporation. In 1962, Snyder founded his first venture, Cambridge Machine Corporation, which initiated the development and invention of high-speed mailing/envelope inserting machines. In 1971, Snyder founded a packaging company, Instapak, which markets “foam-in-place packaging” (revolutionary for its time) that creates a protective barrier for heavy, fragile instrumentation and computer systems. Snyder sold Cambridge Machine Corporation to Pitney-Bowes and he became the National Sales Account manager at Pitney-Bowes. Instapak is now the largest division of Sealed Air Corporation (NYSE: SEE), with more than 5,500 employees and revenues of $1 billion.Genzyme
In 1981, Mr. Snyder founded GenzymeGenzyme
Genzyme Corporation is a fully owned subsidiary of Sanofi-Aventis. Before its acquisition, Genzyme was an American biotechnology company based in Cambridge, Massachusetts. In 2010, Genzyme was the world’s third-largest biotechnology company, employing more than 11,000 people around the world...
and served as Chairman/President/CEO. Genzyme’s business focused on enzyme deficiency diseases. It first produced diagnostic enzymes for victims of Gaucher's disease, a rare chronic disorder causing enormous enlargement of the spleen, a change in skin pigmentation and bone lesions. It afflicts 10,000 young Hasidic Jews each year. It currently employs 10,000 people worldwide, with approximately $3.6 billion in revenues, with a market valuation of $20 billion. Genzyme (NASDAQ:GENZ) is the largest private employer in Boston, Massachusetts. In 1986, Mr. Snyder initiated the first sale of Genzyme stock shares (Initial Public Offering).
Biotage
Mr. Snyder founded Biotage in 1989 which focuses on the development of novel drug development systems. Biotage was acquired by the Swedish biotechnology company Pyrosequencing in 2004 which then took the name Biotage AB.Upstate
In 1994 Snyder founded Argonex a small biotech start-up in Charlottesville, VA. In 1996, Mr. Snyder founded and served as Chairman and Chief Executive Officer Upstate Biotechnology Incorporated merging it with Argonex. Upstate Inc. develops innovative cell signaling products, technology platforms and services to accelerate life science research and drug discovery efforts. Upstate was sold to Serologicals Corporation in 2004 for $205 Million.BioCatalyst International
Biocatalyst International is the most recent of Mr. Snyder’s business enterprises, founded in 2005. Spearheaded by Sherry, Biocatalyst creates sustainable biotech companies in partnership with leading scientists.Biocatalyst International to date incorporates three dynamic companies interfacing with diverse markets of the biotechnology world. These three corporations were founded by Mr. Snyder, as he takes the biotechnology industry into the future. Biocatalyst International, Molecular MD and Xcovery are leading forces catapulting profitable biotech start-up ventures and expanding the boundaries of science today.
Mr. Snyder co-founded Xcovery with Dr. Chris Liang, Director of Medicinal Chemistry, Scripps
Scripps
-People:*Edward W. Scripps, a United States publisher and media financier*Ellen Browning Scripps, La Jolla, California philanthropist, half-sister of Edward W. Scripps...
Research Florida, and co-developer of Sutent, Pfizer
Pfizer
Pfizer, Inc. is an American multinational pharmaceutical corporation. The company is based in New York City, New York with its research headquarters in Groton, Connecticut, United States...
’s first small molecule oncology drug. Xcovery has 5 lead compounds focused on cancer.
Molecular MD was co-founded with Dr. Brian Druker
Brian Druker
Brian J. Druker is a physician-scientist at the Oregon Health & Science University. He is the director of OHSU Knight Cancer Institute, JELD-WEN Chair of Leukemia Research, and professor of medicine...
, inventor of Gleevec, Director of the Cancer Center at the Oregon Health Sciences University in Portland. Oregon. Gleevec is a revolutionary small molecule drug that prevents and stops the growth of cancer cells in chronic myeloid leukemia (CML). MMD is a molecular diagnostic company in the world of personalized medicine utilizing highly sensitive detection systems.
Awards
In 1999, the State of Virginia honored Snyder with its Biotechnology Lifetime Achievement Award.In 2003, he was appointed to Scotland’s International Advisory Board and serves as an advisor to the Scottish government on the development of its biotech sector. In this capacity, Snyder played a major role with the development of an 800000 square feet (74,322.4 m²) bioscience translational center outside of Edinburgh.
Mr. Snyder was honored OBE (Officer of the Order of the British Empire)in 2005 by HM Queen Elizabeth II of the United Kingdom
Elizabeth II of the United Kingdom
Elizabeth II is the constitutional monarch of 16 sovereign states known as the Commonwealth realms: the United Kingdom, Canada, Australia, New Zealand, Jamaica, Barbados, the Bahamas, Grenada, Papua New Guinea, the Solomon Islands, Tuvalu, Saint Lucia, Saint Vincent and the Grenadines, Belize,...
on the advice of the British government.
In 2008 Mr. Snyder was awarded the Intercollegiate Tennis Association
Intercollegiate Tennis Association
The Intercollegiate Tennis Association is an organization of 1,500 coaches and 15,000 collegiate tennis players, encompassing more than 1,000 college tennis programs...
Achievement Award for achievements outside the game of tennis.
He is a member of the Ivy Charitable Foundation.
Philanthropy
Snyder funded and developed the National Junior Tennis League (NJTL), along with the encouragement and support of Arthur AsheArthur Ashe
Arthur Robert Ashe, Jr. was a professional tennis player, born and raised in Richmond, Virginia. During his career, he won three Grand Slam titles, putting him among the best ever from the United States...
and Charles Pasarell. Snyder supported the NJTL for 15 years. This organization now operates, through the USTA, in 110 cities and reaches 250,000 inner-city youths.
In 1988, Snyder was the Founder, Chairman & CEO of Compuflo Inc., which developed a specialty high-end computer program used to analyze airflow to aid the design of aircraft and autos, a company donated to the University of Virginia to support its laboratories. Snyder also funded University Technology Corporation, where companies were formed with University of Virginia technology and the proceeds generated by these business ventures were donated back to the University.
In 1995 Snyder contributed to the construction of a new tennis center at the University of Virginia which was named the Sheridan Snyder Tennis Center
Sheridan Snyder Tennis Center
The Sheridan Snyder Tennis Center at the University of Virginia opened in 1997 right next to Memorial Gymnasium. The 13-court facility showcases Virginia's men's and women's tennis teams.- Configuration :...
.
Snyder's sale of Upstate from in 2004 resulted in a gift of US45 million to the University of Virginia Health Center which has used this gift to construct a new Children's Hospital, the Emily Couric Cancer Center and the Sheridan G. Snyder Translational Research Center.